REGISTERED NUMBER: 14647360 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 28 FEBRUARY 2026

FOR

TEESSIDE PHARMACIES LTD

Page

Company Information

1

Abridged Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Mr N Mushtaque

Mrs S Sharif

REGISTERED OFFICE:

20 Wellesley Road

Middlesbrough

United Kingdom

Cleveland

TS4 2DJ

REGISTERED NUMBER:

14647360 (England and Wales)

ACCOUNTANTS:

Lyons & Co Ltd

23 Yarm Road

Stockton on Tees

TS18 3NJ

FIXED ASSETS

Intangible assets

4

174,995

174,995

Tangible assets

5

2,074

2,766

177,069

177,761

CURRENT ASSETS

Stocks

42,150

19,795

Debtors

89,320

66,829

Cash at bank and in hand

104,473

62,088

235,943

148,712

CREDITORS

Amounts falling due within one year

132,932

303,450

NET CURRENT ASSETS/(LIABILITIES)

103,011

(154,738

)

TOTAL ASSETS LESS CURRENT LIABILITIES

280,080

23,023

CREDITORS

Amounts falling due after more than one year

191,774

60,000

NET ASSETS/(LIABILITIES)

88,306

(36,977

)

CAPITAL AND RESERVES

Called up share capital

2

2

Retained earnings

88,304

(36,979

)

88,306

(36,977

)

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 28 February 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 28 February 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Balance Sheet for the year ended 28 February 2026 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 15 October 2026 and were signed on its behalf by:

Mr N Mushtaque - Director

Mrs S Sharif - Director

1.	STATUTORY INFORMATION

Teesside Pharmacies Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill

Purchased goodwill is valued by the director at the year end and any loss from the original purchase price is amortised in the year. This is in contravention of FRS102 but the director feels this is necessary to show a true and fair view.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery

-

25% on reducing balance

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 6 (2025 - 4 ) .

4.	INTANGIBLE FIXED ASSETS

Totals

£

COST

At 1 March 2025

and 28 February 2026

174,995

NET BOOK VALUE

At 28 February 2026

174,995

At 28 February 2025

174,995

5.	TANGIBLE FIXED ASSETS

Totals

£

COST

At 1 March 2025

and 28 February 2026

3,648

DEPRECIATION

At 1 March 2025

882

Charge for year

692

At 28 February 2026

1,574

NET BOOK VALUE

At 28 February 2026

2,074

At 28 February 2025

2,766

6.	ULTIMATE CONTROLLING PARTY

The ultimate controlling party is Mr N Mushtaque.